History

A list of downloadable documents created during development.

Background information

Colorectal cancer (metastatic) - bevacizumab & cetuximab: appeal

Colorectal cancer (metastatic) - bevacizumab & cetuximab - Final appraisal determination

Colorectal cancer (advanced) - bevacizumab & cetuximab (appraisal consultation document)

Overview

Colorectal cancer (metastatic) - bevacizumab & cetuximab: Assessment report

Consultee and commentator comments on the assessment report

Non-manufacturer submissions

Assessment groups response to comments on the assessment report

Manufacturer submissions

Expert written personal statements

Final protocol

Summary of comments on the draft scope

Final scope

Archive: Draft scope

Summary of comments on the provisional matrix of consultees and commentators

Archive: Provisional matrix of consultees and commentators

2004/027 NICE asked to develop guidance on the care of drug misuse, medicines for prostate cancer, and management of attention deficit hyperactivity disorder